COMMUNIQUÉS West-GlobeNewswire

-
OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data
23/04/2025 -
Hospice Choices: VITAS® Healthcare Expands in Austin, Texas
23/04/2025 -
VivoSim to Carry Forward Organovo 3D Bioprinting
23/04/2025 -
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
23/04/2025 -
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
23/04/2025 -
Arialief Reviews And Complaints (INVESTIGATIVE REPORT) Safe Ingredients for Neuropathy Relief or Over Hype?
23/04/2025 -
Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025
23/04/2025 -
Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation
23/04/2025 -
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
23/04/2025 -
Sagimet Biosciences Announces Upcoming Presentations at EASL Congress 2025
23/04/2025 -
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
23/04/2025 -
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
23/04/2025 -
Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors
23/04/2025 -
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
23/04/2025 -
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
23/04/2025 -
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
23/04/2025 -
Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation
23/04/2025 -
Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
23/04/2025 -
Beghou Consulting Prepares for Next Phase of Growth, Names Adrienne Lovink, Chief Services Officer, to Succeed Beth Beghou, Founder and CEO
23/04/2025
Pages